Announcement on Voluntary Disclosure of External Investment
Filed with SSE · · 6 pages · Chinese
Beijing Sun-Novo Pharmaceutical Research Co. Ltd. on 6ix
Earlier from Beijing Sun-Novo Pharmaceutical Research
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Clinical Trials of BTP4327
- Announcement on Cooperative Investment with Private Fund
- Announcement on Preliminary Earnings Estimate for 2025
- Announcement on Progress in Litigation Involved by the Company
- Announcement on Terminating the Issuance of Shares and Convertible Corporate Bonds to Purchase Assets and Raising Supporting Funds and Related Party Transactions, and the Withdrawal of Application Documents
Later from Beijing Sun-Novo Pharmaceutical Research
- Announcement on the Self-Inspection Report on Insider Trading During the Self-Inspection Period by Persons Aware of Material Non-public Information Related to the Termination of Issuance of Shares and Convertible Corporate Bonds to Acquire Assets, Raising Supporting Funds, and Related Party Transactions
- Announcement on Postponing Term Change of the Board of Directors and Resignation upon Term Expiration of Partial Independent Directors
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of ABA001 Injection
- Announcement on Application for Comprehensive Credit Line and Estimated Amount of Guarantees by the Company and Its Subsidiaries
- for STC008 Injection
Follow Beijing Sun-Novo Pharmaceutical Research into a list and get an email when it puts out news.
Follow Beijing Sun-Novo Pharmaceutical Research